Plain-English translation of NCT06750575 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand how furosemide—a common water pill—affects harmful toxins that build up in people with chronic kidney disease. When your kidneys don't work well, certain toxins that normally get filtered out can accumulate in your blood. This study will measure these toxin levels before and after you start taking furosemide to see whether the medication helps your body remove them or makes them build up more.
Furosemide is prescribed to many kidney disease patients, but doctors aren't sure whether this medication helps or hurts when it comes to removing these harmful toxins from the blood. Understanding this effect is important because reducing toxin buildup could improve outcomes for people living with kidney disease.
You likely qualify if…
You likely don't qualify if…
You will have blood and urine samples collected before you start taking furosemide, and then again after you begin the medication. Your doctor will prescribe furosemide as part of your regular kidney disease care—the study doesn't change your treatment plan. The study team will measure the levels of harmful toxins in your blood and how much is being removed in your urine to see what effect the medication has.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Netherlands